Mayo Clinic May 26, 2024
John Halamka

A closer look at the latest FDA list of approved AI-enabled devices suggests these digital tools are poised to have a significant impact on patient care.

By John Halamka, M.D., President, Mayo Clinic Platform and Paul Cerrato, MA, senior research analyst and communications specialist, Mayo Clinic Platform

There was a time in the not-too-distant past when physicians and nurses paid little attention to AI/ML-based medical devices, viewing them as novelties not useful bedside tools. That has drastically changed in the last five years. Consider the latest list of such medical devices, updated in May 2024 and published by the FDA. It includes devices that were marketed via 510k clearance, DeNovo request, and premarket approval.

The majority of these digital...

Today's Sponsors


Today's Sponsor


Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Patient / Consumer, Physician, Provider, Technology
Generative AI And Brain Rot
Declining pay and 3 other trends to watch, per 1 healthcare leader
Streamlining Hospital Operations, Optimizing Resource Allocation, and Improving Efficiency with AI Predictive Analytics and Machine Learning Algorithms
McKinsey accelerates gen AI value creation with Iguazio
Five Steps CEOs Can Take To Protect Data In The Age Of AI

Share This Article